Table 2 AKR1C3 Singleplex IHC 2 × 2 analysis in T-ALL.
From: AKR1C3 expression in T acute lymphoblastic leukemia/lymphoma for clinical use as a biomarker
IHC cutoff ≥ 20% gr2 | ≥ 20% ALL blast % | ||
|---|---|---|---|
Positive | Negative | Total | |
Positive | 7 | 1 | 8 |
Negative | 0 | 8 | 8 |
Total | 7 | 9 | 16 |
